QUIDELORTHO CORP (QDEL) Shareholder Equity
- 2026-06-28: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $100.00K; Additional Paid in CapitalUSD $2.95B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $800.00K.
- 2026-03-29: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $100.00K; Additional Paid in CapitalUSD $2.94B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-4.10M.
- 2025-12-28: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $100.00K; Additional Paid in CapitalUSD $2.93B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-15.40M.
- 2025-09-28: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $100.00K; Additional Paid in CapitalUSD $2.92B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-19.70M.
QUIDELORTHO CORP Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments USD | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-28 | $0.00 | $100.00K | $2.95B | $800.00K | $-1.18B | $1.77B | (m) | 3 month · $12.00M | (m) | (m) | (m) |
| 2026-03-29 | $0.00 | $100.00K | $2.94B | $-4.10M | $-1.09B | $1.85B | (m) | 3 month · $10.70M | (m) | (m) | (m) |
| 2025-12-28 | $0.00 | $100.00K | $2.93B | $-15.40M | $-996.00M | $1.92B | $-15.40M | 12 month · $45.50M | 12 month · $21.80M | (m) | (m) |
| 2025-09-28 | $0.00 | $100.00K | $2.92B | $-19.70M | $-865.30M | $2.04B | (m) | 3 month · $10.60M | (m) | (m) | (m) |
| 2025-06-29 | $0.00 | $100.00K | $2.91B | $16.20M | $-132.30M | $2.79B | (m) | 3 month · $12.70M | (m) | (m) | (m) |
| 2025-03-30 | $0.00 | $100.00K | $2.90B | $-23.80M | $123.10M | $3.00B | $-23.80M | 3 month · $11.40M | 3 month · $6.80M | (m) | (m) |
| 2024-12-29 | $0.00 | $100.00K | $2.88B | $-36.20M | $135.80M | $2.98B | $-36.20M | 12 month · $41.00M | 12 month · $34.30M | (m) | (m) |
| 2024-09-29 | $0.00 | $100.00K | $2.88B | $-3.50M | $314.20M | $3.19B | $-3.50M | 3 month · $12.00M | 3 month · $10.10M 9 month · $27.10M | (m) | (m) |
| 2024-06-30 | $0.00 | $100.00K | $2.86B | $-24.60M | $334.10M | $3.17B | $-24.60M | 3 month · $10.30M | 3 month · $9.10M 6 month · $17.00M | (m) | (m) |
| 2024-03-31 | $0.00 | $100.00K | $2.85B | $-26.20M | $481.80M | $3.31B | $-26.20M | 3 month · $9.00M | 3 month · $7.90M | (m) | (m) |
| 2023-12-31 | $0.00 | $100.00K | $2.85B | $-30.00M | $2.19B | $5.01B | $-30.00M | 12 month · $50.90M | 12 month · $24.90M | (m) | (m) |
| 2023-10-01 | $0.00 | $100.00K | $2.84B | $-53.20M | $2.18B | $4.97B | $-53.20M | 3 month · $13.50M | 3 month · $6.30M 9 month · $16.30M | (m) | (m) |
| 2023-07-02 | $0.00 | $100.00K | $2.83B | $-16.30M | $2.19B | $5.00B | $-16.30M | 3 month · $13.70M | 3 month · $4.30M 6 month · $10.00M | (m) | (m) |
| 2023-04-02 | $0.00 | $100.00K | $2.81B | $-59.30M | $2.25B | $5.00B | $-59.30M | 3 month · $10.40M | 3 month · $5.70M | (m) | (m) |
| 2023-01-01 | $0.00 | $0.00 | $2.80B | $-67.60M | $2.20B | $4.93B | $-67.60M | 12 month · $45.10M | 12 month · $5.20M | (m) | (m) |
| 2022-10-02 | $0.00 | $0.00 | $2.77B | $-144.50M | $2.17B | $4.80B | $-144.50M | 3 month · $12.60M | 3 month · $200.00K 9 month · $-700.00K | (m) | (m) |
| 2022-07-03 | $0.00 | $0.00 | $2.83B | $-60.70M | $2.15B | $4.92B | $-60.70M | 3 month · $14.70M | 3 month · $-1.00M 6 month · $-900.00K | (m) | (m) |
| 2022-04-03 | (m) | (m) | (m) | (m) | (m) | $2.41B | $200.00K | 3 month · $6.20M | (m) | (m) | (m) |
| 2022-01-02 | $0.00 | $0.00 | $279.80M | $400.00K | $1.65B | $1.93B | $400.00K | 12 month · $22.70M | (m) | (m) | (m) |
| 2021-10-03 | (m) | (m) | (m) | (m) | (m) | $1.63B | (m) | 3 month · $5.60M | (m) | (m) | (m) |
| 2021-07-04 | (m) | (m) | (m) | (m) | (m) | $1.41B | (m) | 3 month · $5.80M | (m) | (m) | (m) |
| 2021-04-04 | (m) | (m) | (m) | (m) | (m) | $1.49B | (m) | 3 month · $5.90M | (m) | (m) | (m) |
| 2021-01-03 | (m) | (m) | (m) | (m) | (m) | $1.33B | (m) | 12 month · $19.00M | (m) | 12 month · $26.20M | 12 month · $100.00K |
| 2019-12-29 | (m) | (m) | (m) | (m) | (m) | $559.90M | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |